-
-
Fosun’s Fintech Business Enters Harvest Period, Finloop Projects Asset Management Scale to Surge 10-Fold in a Year
2024-06-12
(12 June 2024) Finloop Finance Technology Holding Limited (“Finloop”), a leading digital intelligent wealth management platform independently incubated by Fosun Wealth International Holdings Limited (“Fosun Wealth”), a subsidiary of Fosun International (00656.HK), announced today that it has entered into strategic cooperation agreements with multiple leading fintech companies
-
-
Corporate Governance Asia’s CEOs Interview – Fosun Advances Sustainable Development to Create a Better World
2024-06-07
The most authoritative corporate governance magazine in the Asia Pacific region, Corporate Governance Asia, has recently presented the 14th Asian Excellence Award. Chen Qiyu and Xu Xiaoliang, Executive Directors and Co-CEOs of Fosun International, were awarded Asia’s Best CEO by the magazine.Corporate Governance Asiapointed out that, in 2023, despite
-
-
Henlius Trastuzumab Begins its Journey to Saudi Arabia
2024-06-06
·HANQUYOU is poised to be the first Chinese monoclonal antibody to enter the Middle Eastern market, further expanding its global presence.·HANQUYOU was approved in more than 40 countries and regions around the world.·With the first shipment to the Middle East, Henlius has realized commercialized supply across China, Europe, Southeast Asia, Latin America,
-
-
Wang Qunbin: Deepening Fosun’s Presence in Portugal for a Decade, Leveraging Global Operations to Promote New Development
2024-06-05
On 4 June 2024,Lisbon, Portugal, Chinese Minister of Commerce Wang Wentao chaired a roundtable with representatives from Chinese enterprises operating in Portugal. Representatives from Chinese enterprises engaged in sectors such as energy, finance, construction, and telecommunications in Portugal attended the roundtable, during which they shared the deve
-
-
Fosun International Garners Four Awards from Corporate Governance Asia Chen Qiyu and Xu Xiaoliang, Executive Directors and Co-CEOs of Fosun International win Asia’s Best CEO from Corporate Governance Asia
2024-06-04
Fosun International receives Sustainable Asia Award and Best Corporate Communications AwardOn 31 May 2024, themagazineCorporate Governance Asiapresented the 14th Asian Excellence Award. Chen Qiyu and Xu Xiaoliang, Executive Directors and Co-CEOs of Fosun International Limited (“Fosun International”or “Fosun”or the “Group”) (HKEX stock code: 00656) were both
-
-
Fosun Wealth Holdings - Virtual Asset Dealing Service License is Initially Approved by Hong Kong SFC
2024-05-31
[Hong Kong –May 31, 2024] Fosun International Securities Limited(hereafter “Fosun International Securities”), subsidiary of Fosun Wealth International Holdings Limited(hereafter "Fosun Wealth Holdings"),has received preliminary approvalfromthe Securities and Futures Commissionof Hong Kong("SFC")to provide virtual asset dealing services. This impor
-
-
Protechting 6.0 China Roadshow 2024
2024-05-30
-
-
Guo Guangchang: Let’s Invest in Shanghai and Share the Future!
2024-05-26
On 23 May, the “Invest in Shanghai, Sharethe Future” Overseas Promotion Campaign (New York, U.S.) was successfully heldin New York. Shanghai Mayor Gong Zheng delivered a keynote speech at thepromotion event, said, “Shanghai is speeding up the process of building itselfinto an international center of economy, finance, trade, shipping, andtechnologica
-
-
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
2024-05-24
Shanghai, China & JERSEYCITY, N.J. – May 24, 2024 – Shanghai Henlius Biotech, Inc. (2696.HK) andOrganon (NYSE: OGN) today announced that the European Medicines Agency (EMA)has validated the marketing authorization applications (MAAs) for HLX14, aninvestigational Prolia®and Xgeva®(denosumab)biosimilar. Denosumab has been approved in various countries and regi